UK claims successes in meeting cancer and CVD mortality reduction targets
This article was originally published in Clinica
Executive Summary
England is claiming early successes in meeting its targets for reducing cancer- and cardiovascular disease-related mortality among the under-75s. The annual update announced today by the Department of Health, which includes 2005-07 data, features: an 18.2% fall (since the baseline) in three-year average mortality rates for cancer, which is said to be on course to meet the 20% reduction target by 2009-11; and a 44% cut in three-year average mortality rates for circulatory diseases, thereby meeting ahead of schedule the minimum target of 40% by 2009-11, claims the DH.
You may also be interested in...
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.